Noteworthy Cases & Achievements:
Ms. Hart serves on the Steering Committee of the In re Packaged Seafood Antitrust Litigation prosecuting allegations of price fixing against the world’s largest tuna producers. In 2015, Ms. Hart, represented a doctor-whistleblower alleging false Medicaid billing and recovered a partial settlement of $22.4 million, the largest single New York Medicaid fraud recovery to date. In 2014, Ms. Hart tried a limited partnership dispute and after multiple days of testimony and oral argument won a multi-million dollar award. In 2013, Ms. Hart, recovered $219 million for upstate New York trade unions who had lost their pensions in the Madoff Ponzi scheme. Judge McMahon praised the “unprecedented global settlement” and recognized that Ms. Hart “carried the laboring oar.” Judge McMahon continued: “Your clients – all of them – have been well served . . . rarely has there been a more transparent settlement negotiation. It could serve as a prototype.”
Ms. Hart was Lead Counsel in the In re Juniper Networks Securities Litigation (N.D. Cal.) involving allegations of massive options backdating and gained a $169,000,000 settlement that the Hon. James Ware called an “excellent result.” The recovery was the third largest of any of the dozens of litigations involving options backdating. Ms. Hart served as lead counsel representing the Office of the Treasurer of the State of Connecticut in the In re Waste Management Securities Litigation, which settled for $457 million; then the third-largest securities class action settlement. Ms. Hart served as co-lead counsel in the In re Air Cargo Antitrust Litigation (E.D.N.Y) one of the largest collusion cases in history involving most of the world’s major airlines. Ms. Hart was co-lead counsel in the In re El Paso Corporation Securities Litigation, garnering a $285 million settlement. A few of her notable antitrust settlements include: In re Stock Exchange Options Trading Antitrust Litigation ($47 million settlement); In re Brand Name Drug Litigation ($65 million settlement); In re Augmentin Antitrust Litigation ($29 million settlement); In re Paxil Antitrust Litigation ($65 million settlement); In re Sodium Erythorbate and Maltol Antitrust Litigation ($18.45 million settlement); In re Synthroid Marketing and Antitrust Litigation ($87.4 million settlement); and In re Warfarin Sodium Antitrust Litigation ($44.5 million settlement). On behalf of her clients Ms. Hart pushed for reform to both New York’s Martin and Donnelly Acts. Ultimately, her efforts led to an amendment making New York an “Illinois Brick” repealer state, granting standing to injured New Yorkers. This precipitated similar amendments in other states. Ms. Hart co-edited the New York Antitrust and Consumer Protection Law handbook. Ms. Hart has successfully represented institutional investor clients as amici curiae on various matters, including on New York’s Martin Act.
B.A. Vanderbilt University (1982)
M.A. University of North Carolina (1987)
J.D. Fordham University School of Law (1992), Dean’s List, member of the Law Review
Ms. Hart is admitted to practice in New York and Connecticut, and is a member of the bars of the U.S. Supreme Court; the U.S. Courts of Appeals for the 2nd, 3rd, and 7th Circuits; and the U.S. District Courts for the Southern and Eastern Districts of New York.